Current Topics in Medicinal Chemistry


Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Editorial [Hot Topic: TB Drug Development (Guest Editor: Courtney C. Aldrich)] promotion: free to download

Volume:12   Issue: 7
Pp: 671-671
Courtney C. Aldrich
DOI: 10.2174/156802612799984553
Published on: 18 March, 2012

Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds open access plus

Volume:12   Issue: 7
Pp: 672-693
Pan Pan and Peter J. Tonge
DOI: 10.2174/156802612799984535
Published on: 18 March, 2012

Drug Design and Identification of Potent Leads Against Mycobacterium tuberculosis Thymidine Monophosphate Kinase

Volume:12   Issue: 7
Pp: 694-705
S. Van Calenbergh, S. Pochet and H. Munier-Lehmann
DOI: 10.2174/156802612799984580
Published on: 18 March, 2012

Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis

Volume:12   Issue: 7
Pp: 729-734
Annamaria Lilienkampf, Marco Pieroni, Scott G. Franzblau, William R. Bishai and Alan P. Kozikowski
DOI: 10.2174/156802612799984544
Published on: 18 March, 2012

Natural Products as Leads for Tuberculosis Drug Development open access plus

Volume:12   Issue: 7
Pp: 735-765
Christine E. Salomon and Lori E. Schmidt
DOI: 10.2174/156802612799984526
Published on: 18 March, 2012

Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets

Volume:12   Issue: 7
Pp: 766-796
Benjamin P. Duckworth, Kathryn M. Nelson and Courtney C. Aldrich
DOI: 10.2174/156802612799984571
Published on: 18 March, 2012


Volume:12   Issue: 7
Pp: 797-797
Emilio Jirillo
DOI: 10.2174/156802612799984562
Published on: 18 March, 2012